Financhill
Sell
50

MDGL Quote, Financials, Valuation and Earnings

Last price:
$308.99
Seasonality move :
15.43%
Day range:
$293.00 - $312.52
52-week range:
$168.25 - $368.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.66x
Volume:
696.5K
Avg. volume:
390.4K
1-year change:
39.66%
Market cap:
$6.7B
Revenue:
--
EPS (TTM):
-$25.12

Earnings Data

Next earnings date for MDGL
Feb 28
2025
Most recent earnings per share
-$4.92
Beat by $1.99
(Oct 31/2024)
Consensus Estimate
-$6.91
(Oct 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MDGL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $91.3M -- -- -$4.36 --
10/31/2024 Q3 $34.4M $62.2M -$4.92 -$6.91 $1.99
08/07/2024 Q2 $4.4M $14.6M -$7.10 -$7.66 $0.56
05/07/2024 Q1 -- -- -$7.38 -$6.39 -$0.99
02/28/2024 Q4 -- -- -$5.72 -$5.34 -$0.38
11/06/2023 Q3 -- -- -$5.34 -$4.93 -$0.41
08/08/2023 Q2 -- -- -$4.69 -$4.54 -$0.15
05/09/2023 Q1 -- -- -$4.23 -$4.78 $0.55
02/23/2023 Q4 -- -- -$4.98 -$4.61 -$0.37
11/03/2022 Q3 -- -- -$4.75 -$4.18 -$0.57
08/04/2022 Q2 -- -- -$4.14 -$3.64 -$0.50
05/09/2022 Q1 -- -- -$3.36 -$3.54 $0.18
02/24/2022 Q4 -- -- -$3.78 -$3.91 $0.13
11/04/2021 Q3 -- -- -$3.79 -$3.85 $0.06
08/05/2021 Q2 -- -- -$3.72 -$3.54 -$0.18
05/06/2021 Q1 -- -- -$3.32 -$3.89 $0.57
02/25/2021 Q4 -- -- -$3.82 -$3.90 $0.08
11/05/2020 Q3 -- -- -$3.75 -$3.30 -$0.45
08/06/2020 Q2 -- -- -$3.18 -$2.43 -$0.75
05/07/2020 Q1 -- -- -$2.34 -$1.95 -$0.39
02/26/2020 Q4 -- -- -$1.80 -$1.67 -$0.13
11/06/2019 Q3 -- -- -$1.39 -$1.42 $0.03
08/07/2019 Q2 -- -- -$1.28 -$1.22 -$0.06
05/08/2019 Q1 -- -- -$0.98 -$0.97 -$0.01
02/27/2019 Q4 -- -- -$0.76 -$0.74 -$0.02
11/06/2018 Q3 -- -- -$0.56 -$0.53 -$0.03
08/07/2018 Q2 -- -- -$0.45 -$0.62 $0.17
04/13/2018 Q1 -- -- -$0.45 -$0.77 $0.32
12/31/2017 Q4 -- -- -$0.67 -$0.70 $0.03
11/09/2017 Q3 -- -- -$0.68 -$0.79 $0.11
08/10/2017 Q2 -- -- -$0.69 -$0.60 -$0.09
04/03/2017 Q1 -- -- -$0.50 -$0.87 $0.37

Madrigal Pharmaceuticals Earnings Questions

  • How Much did Madrigal Pharmaceuticals Generate in Revenue Last Quarter?

    Madrigal Pharmaceuticals reported $62.2M worth of top line sales in its most recent quarter.

  • Did Madrigal Pharmaceuticals Beat Earnings Last Quarter?

    Madrigal Pharmaceuticals announced earnings per share of -$4.92 which represents a beat of analyst forecast a -$6.91 per share.

  • Is Madrigal Pharmaceuticals Profitable?

    Madrigal Pharmaceuticals reported $60M that represents $2.76 per share over the last quarter.

  • What is the Analyst Consensus for Madrigal Pharmaceuticals EPS Next Year?

    Madrigal Pharmaceuticals's earnings are forecast to decrease from -$19.99 per share to -$19.53 per share next year representing a decrease of -18.42%.

  • When is Madrigal Pharmaceuticals's Earnings Date?

    Madrigal Pharmaceuticals's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock